Matches in Nanopublications for { ?s ?p "Saxagliptin (rINN) is an orally active hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. FDA approved on July 31, 2009."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.